Aram Sicras-Navarro

455 total citations
21 papers, 275 citations indexed

About

Aram Sicras-Navarro is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Aram Sicras-Navarro has authored 21 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Surgery. Recurrent topics in Aram Sicras-Navarro's work include Diabetes Treatment and Management (5 papers), Cardiovascular Function and Risk Factors (4 papers) and Heart Failure Treatment and Management (4 papers). Aram Sicras-Navarro is often cited by papers focused on Diabetes Treatment and Management (5 papers), Cardiovascular Function and Risk Factors (4 papers) and Heart Failure Treatment and Management (4 papers). Aram Sicras-Navarro collaborates with scholars based in Spain, United Kingdom and United States. Aram Sicras-Navarro's co-authors include Antoni Sicras‐Mainar, Beatriz Palacios, Luis Varela, Juan F. Delgado, Andrea Gabilondo, Víctor Pérez, Miquel Roca, Eduard Vieta, Jordi Alonso and Ivan Hernandez and has published in prestigious journals such as Journal of Affective Disorders, Journal of the Neurological Sciences and Value in Health.

In The Last Decade

Aram Sicras-Navarro

19 papers receiving 272 citations

Peers

Countries citing papers authored by Aram Sicras-Navarro

Since Specialization

Citations

This map shows the geographic impact of Aram Sicras-Navarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aram Sicras-Navarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aram Sicras-Navarro more than expected).

Fields of papers citing papers by Aram Sicras-Navarro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aram Sicras-Navarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aram Sicras-Navarro. The network helps show where Aram Sicras-Navarro may publish in the future.

Co-authorship network of co-authors of Aram Sicras-Navarro

This figure shows the co-authorship network connecting the top 25 collaborators of Aram Sicras-Navarro. A scholar is included among the top collaborators of Aram Sicras-Navarro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aram Sicras-Navarro. Aram Sicras-Navarro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-World Osteoporosis Treatment Gap and Costs in Spain: Data from Women with a First Fragility Fracture or Diagnosis of Postmenopausal Osteoporosis 2025 ·Rheumatology and Therapy ·Antoni Sicras‐Mainar, (unknown), (unknown), (unknown), Aram Sicras-Navarro, (unknown), (unknown), (unknown)	2
2	Disease burden and costs for patients with hip and knee osteoarthritis and chronic moderate-to-severe refractory pain on treatment with strong opioids in Spain 2023 ·Reumatología Clínica (English Edition) ·Antoni Sicras‐Mainar, Javier Rejas, (unknown), Carlos Tornero, Aram Sicras-Navarro, (unknown)	0
3	Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain 2022 ·International Journal of COPD ·(unknown), (unknown), Afisi Ismaila, Antoni Sicras‐Mainar, Aram Sicras-Navarro, Cruz González, (unknown), (unknown), (unknown)	1
4	Achieving Lower LDL-C Levels After a Recent Myocardial Infarction Might Be Associated with Lower Healthcare Resource Use and Costs in Spain 2022 ·Advances in Therapy ·(unknown), Guillermo Villa, (unknown), (unknown), J Lozano, (unknown), (unknown), Aram Sicras-Navarro, Antoni Sicras‐Mainar	1
5	Persistence, use of resources and costs in patients under migraine preventive treatment: the PERSEC study 2022 ·The Journal of Headache and Pain ·Pablo Irimia, David García‐Azorín, Mercedes Núñez, Silvia Díaz‐Cerezo, Pepa Polavieja, (unknown), Aram Sicras-Navarro, Antoni Sicras‐Mainar, Antonio Ciudad	22
6	Epidemiology and resource use in Spanish type 2 diabetes patients without previous cardiorenal disease: CaReMe Spain study summary 2022 ·Endocrinología Diabetes y Nutrición (English ed ) ·Antoni Sicras‐Mainar, Aram Sicras-Navarro, Beatriz Palacios, (unknown), Julia Blanco, (unknown), Nicolás Manito, Roberto Alcázar Arroyo, (unknown)	2
7	Disease burden and costs for patients with hip and knee osteoarthritis and chronic moderate-to-severe refractory pain on treatment with strong opioids in Spain 2022 ·Reumatología Clínica ·Antoni Sicras‐Mainar, Javier Rejas, (unknown), Carlos Tornero, Aram Sicras-Navarro, (unknown)	0
8	Disease Burden and Costs in Moderate-to-Severe Chronic Osteoarthritis Pain Refractory to Standard of Care: Ancillary Analysis of the OPIOIDS Real-World Study 2021 ·Rheumatology and Therapy ·Antoni Sicras‐Mainar, Javier Rejas, (unknown), Carlos Tornero, Aram Sicras-Navarro, (unknown)	9
9	Epidemiology and costs of depressive disorder in Spain: the EPICO study 2021 ·European Neuropsychopharmacology ·Eduard Vieta, Jordi Alonso, Víctor Pérez, Miquel Roca, (unknown), Antoni Sicras‐Mainar, Aram Sicras-Navarro, (unknown), Andrea Gabilondo	38
10	Economic Consequences of the Overuse of Short-Acting ß-Adrenergic Agonists in the Treatment of Asthma in Spain 2021 ·Journal of Investigational Allergology and Clinical Immunology ·Antonio Valero, (unknown), Javier Nuevo, Stacey L. Simon, Margarita Capel, Antoni Sicras‐Mainar, Aram Sicras-Navarro, Vicente Plaza	4
11	Clinical characteristics, management, and one-year risk of complications among patients with heart failure with and without type 2 diabetes in Spain 2021 ·Revista Clínica Española (English Edition) ·Carlos Escobar, Luis Varela, Beatriz Palacios, Margarita Capel, Antoni Sicras‐Mainar, Aram Sicras-Navarro, (unknown), Roberto Alcázar Arroyo, Nicolás Manito, Manuel Botana	6
12	Epidemiology and resource use in Spanish type 2 diabetes patients without previous cardiorenal disease: CaReMe Spain study summary 2021 ·Endocrinología Diabetes y Nutrición ·Antoni Sicras‐Mainar, Aram Sicras-Navarro, Beatriz Palacios, (unknown), Julia Blanco, (unknown), Nicolás Manito, Roberto Alcázar Arroyo, (unknown)	4
13	Economic impact of treatment-resistant depression: A retrospective observational study 2021 ·Journal of Affective Disorders ·Víctor Pérez, Miquel Roca, Jordi Alonso, Andrea Gabilondo, (unknown), Antoni Sicras‐Mainar, Aram Sicras-Navarro, (unknown), Eduard Vieta	32
14	Persistence, use of resources and costs in patients who start preventive medication for the treatment of migraine in Spain: The persec study 2021 ·Journal of the Neurological Sciences ·Pablo Irimia, David García‐Azorín, Mercedes Núñez, Silvia Díaz‐Cerezo, Pepa Polavieja, (unknown), Aram Sicras-Navarro, Antoni Sicras‐Mainar, Antonio Ciudad	1
15	Persistencia al tratamiento con metformina de marca vs. genérica en monoterapia para la diabetes tipo 2: estudio retrospectivo de vida real mediante propensity score matching 2021 ·Medicina de Familia SEMERGEN ·Antoni Sicras‐Mainar, Aram Sicras-Navarro	1
16	All-cause community acquired pneumonia cost by age and risk in real-world conditions of care in Spain 2021 ·Expert Review of Pharmacoeconomics & Outcomes Research ·Javier Rejas, Antoni Sicras‐Mainar, Aram Sicras-Navarro, (unknown), Cristina Méndez	7
17	Características clínicas, manejo y riesgo de complicaciones a un año en pacientes con insuficiencia cardíaca con y sin diabetes tipo 2 en España 2021 ·Revista Clínica Española ·Carlos Escobar, Luis Varela, Beatriz Palacios, Margarita Capel, Antoni Sicras‐Mainar, Aram Sicras-Navarro, (unknown), Roberto Alcázar Arroyo, Nicolás Manito, Manuel Botana	11
18	Epidemiology and treatment of heart failure in Spain: the HF-PATHWAYS study 2020 ·Revista Española de Cardiología (English Edition) ·Antoni Sicras‐Mainar, Aram Sicras-Navarro, Beatriz Palacios, Luis Varela, Juan F. Delgado	42
19	Epidemiología y tratamiento de la insuficiencia cardiaca en España: estudio PATHWAYS-HF 2020 ·Revista Española de Cardiología ·Antoni Sicras‐Mainar, Aram Sicras-Navarro, Beatriz Palacios, Luis Varela, Juan F. Delgado	49
20	PMU146 VALIDATION AND REPRESENTATIVENESS OF THE SPANISH BIG-PAC DATABASE: INTEGRATED COMPUTERIZED MEDICAL RECORDS FOR RESEARCH INTO EPIDEMIOLOGY, MEDICINES AND HEALTH RESOURCE USE (REAL WORD EVIDENCE) 2019 ·Value in Health ·(unknown), J.L. Enriquez, Ivan Hernandez, Aram Sicras-Navarro, (unknown), (unknown)	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact